Grants and Contributions:
Title:
ARP - Development of a medical device for oxygen therapy
Agreement Number:
902174
Agreement Value:
$48,735.00
Agreement Date:
Apr 2, 2018 - Jul 26, 2019
Description:
Develop a prototype, which allows the management of high intensity gas flows (5 to 100 L/min) (mixture of oxygen and air) automatically by varying the proportion of each gas based on oxygenation of patients (SpO2).
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Quebec, Quebec, CA G2J 0C4
Reference Number:
172-2018-2019-Q3-902174
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
816729628
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 2 time(s). The end date of this agreements has been modified by 133 days.
Amendment Date
Mar 28, 2019
Recipient's Legal Name:
Oxy'Nov inc.
Federal Riding Name:
Louis-Saint-Laurent
Federal Riding Number:
24045
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
339110
Amendments: